Soliqua 100/33 (Insulin Glargine and Lixisenatide PFS) 100/33mcg-3ml

Soliqua 100/33 is a pre-filled pen injection combining insulin glargine and lixisenatide for type 2 diabetes management. This combination therapy supports blood sugar control with a single daily dose. Ideal for patients seeking simplified diabetes treatment options.

Strength

100/33mcg-3ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Sanofi Aventis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Soliqua 100/33 is used to improve blood sugar levels in adults with type 2 diabetes. It combines two medications, insulin glargine and lixisenatide, to provide better glycemic control. This combination therapy is often prescribed when diet, exercise, and oral medications alone are not enough. It helps manage blood sugar throughout the day and after meals.

Side Effects

Soliqua 100/33 works by mimicking natural hormones to regulate blood sugar. Insulin glargine helps lower blood sugar levels by increasing insulin production, while lixisenatide slows digestion and reduces appetite. Users may notice steadier energy levels and reduced food cravings. Effects vary by individual and are best monitored with regular blood sugar testing.

Precautions & Warnings

Store Soliqua 100/33 at room temperature, away from heat and direct light. Keep pens and needles out of reach of children and pets. Do not freeze or expose to extreme temperatures. Always check the pen for particles or discoloration before use. Dispose of used needles safely in a sharps container.

Avoid Interactions

Soliqua 100/33 may interact with other diabetes medications, blood pressure drugs, or corticosteroids. Alcohol and certain antibiotics can affect blood sugar levels when combined with this medication. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

Soliqua 100/33 is used to improve blood sugar control in adults with type 2 diabetes.

It is administered as a subcutaneous injection once daily, typically before the first meal.

Yes, combining insulin with other diabetes medications may increase the risk of low blood sugar.

Consult a healthcare provider to determine if this medication is appropriate for your condition.

Take the missed dose as soon as you remember, unless it is almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.